Abstract:Objectives: Placental inflammation possibly underlies preeclampsia pathogenesis. This study aimed to investigate the expression of the high mobility box group 1 (HMGB1)-toll-like receptor 4 (TLR4) signalling pathway in preeclamptic placentas and determine whether HMGB1 regulates the biological behaviour of trophoblasts in vitro. Design: Placental biopsies were taken from 30 preeclamptic patients and 30 normotensive controls. In vitro experiments were carried out in HTR-8/SVneo human trophoblast cells. Participants/Materials, Setting, Methods: HMGB1, TLR4, and nuclear factor kappa B (NF-κB) mRNA and protein were quantified to compare their expression in human placentas from preeclamptic and normotensive pregnancies. HTR-8/SVneo cells were stimulated with HMGB1 (50 – 400 μg/L) for 6 – 48 h, and proliferation and invasion of HTR-8/SVneo cells were measured via Cell Counting Kit-8 and transwell assays. HTR-8/SVneo cells were also transfected with HMGB1 and TLR4 siRNA to investigate the effect of knocking down these proteins. The mRNA and protein expression of TLR4, NF-κB, and matrix metalloproteinase 9 (MMP-9) were determined using qPCR and western blotting, respectively. Data were analysed with either a t-test or one-way analysis of variance. Results The mRNA and protein levels of HMGB1, TLR4, and NF-κB were significantly higher in the placentas from preeclamptic pregnancies than from normal pregnancies (P < 0.05). HMGB1 stimulation (at concentrations up to 200 μg/L) of HTR-8/SVneo cells significantly increased invasion and proliferation over time. However, at an HMGB1 stimulation concentration of 400 μg/L, the invasion and proliferation ability of HTR-8/SVneo cells decreased. Compared to controls, mRNA and protein expression levels of TLR4, NF-κB, and MMP-9 increased (mRNA level fold change: 1.460, 1.921, 1.667; protein level fold change: 1.600, 1.750, 2.047) when stimulated with HMGB1 (P < 0.05) but decreased when HMGB1 was knocked down (P < 0.05). TLR4 siRNA transfection combined with HMGB1 stimulation reduced the mRNA (fold change: 0.451) and protein (fold change: 0.289) expression of TLR4 (P 0.05). Limitations Only one trophoblast cell line was used in this study, and the findings were not confirmed in animal studies. Conclusions This study explored the pathogenesis of preeclampsia from two aspects: inflammation and trophoblast invasion. The overexpression of HMGB1 in placentas from preeclamptic pregnancies suggests this protein may be involved in preeclampsia pathogenesis. In vitro, HMGB1 was found to regulate the proliferation and invasion of HTR-8/SVneo cells by activating the TLR4-NF-κB-MMP-9 pathway. These findings have implications for targetting HMGB1 could be a therapeutic strategy for treating PE. In the future, we will further verify this in vivo and in other trophoblast cell lines, further exploring the molecular interactions of the pathway.

Human Leukocyte Antigen HLA-C, HLA-G, HLA-F and HLA-E placental profiles are altered in Early Severe Preeclampsia and Preterm Birth with Chorioamnionitis.

Placental macrophages present distinct polarization pattern and effector functions depending on clinical onset of preeclampsia

Expression of human leukocyte antigen-G during normal placentation and in preeclamptic pregnancies.

Expression of Various Subtypes of HLA-G Mrna in Placentas of Pregnant Women Complicated with Severe Preeclampsia

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Declined placental PLAC1 expression is involved in preeclampsia.

Three types of HLA-G+ extravillous trophoblasts that have distinct immune regulatory properties

Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.

The expression of HLA-G Mrna isoforms in placentas from women with preeclampsia and normal pregnancy

Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia

Effect of Granzyme K, FasL and Interferon-γ Expression in Placentas with Preeclampsia

Attenuation of EZH2-mediated H3K27 Methylation Up-Regulates STAT5B Expression During Trophoblast Syncytialization

Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia

[Expression of Human Leucocyte Antigen G on Human Placenta and Its Gene Polymorphism in Relation to Intrahepatic Cholestasis of Pregnancy].

Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia

Roles of HLA-G in the Maternal-Fetal Immune Microenvironment

Expression of HMGB1-TLR4 in placentas from preeclamptic pregnancies and its effect on proliferation and invasion of HTR-8/SVneo cells

High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia

Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies